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lance AR in CAP to provide information for judicious antibiotic
use for the containment of AR.
Methods: A cross-sectional observational study was carried out in
patients hospitalized with CAP. Patients were identiﬁed through
daily visits to emergency and medicine wards and were followed
from day of admission till the day of discharge from hospital.
Severity of disease was assessed with help of severity assessment
scales like PSI. The rates of AR were analyzed with help of
WHO.net 5.4 software.
Results: The most common pathogen isolated causing CAP were
S. pneumoniae 31 (25.62%), K. pneumonia 24 (19.83%), H. in-
ﬂuenza 18 (14.87%), S. aureus 16 (13.22%), P. aeruginosa 14
(6.7%), and M. pneumoniae 7 (5.9%). S. pneumoniae resistance
was high for penicillin (PEN) (45%), cefazoline (CZO) (40%), and
erythromycin (ERY) (39%) with low resistance for ciproﬂoxacin
(CIP) (8%) and oﬂoxacin (OFX) (14%).
K. pneumoniae resistance was high for ampicillin (AMP) (81%)
with good susceptibility to imipenam (IPM) (100%), chloram-
phenicol (CHL) (90%), gentamicin (GEN) (87%). H. inﬂuenzae had
high resistance for ERY while susceptibility was good (above 85%)
for antibiotics like (GEN, CIP, IPM.)
Conclusion: S. pneumoniae was found to be most common
pathogen in CAP. Incidence of gram negative pathogens (K.
pneumoniae, P. aeruginosa) causing CAP was high. Infection by
resistant pathogen had impact both on severity of disease and
outcome.
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Dana Huang*, Yijie Geng, Renli Zhang. Shenzhen Center for
Diseases Control and Prevention
Objective: Preparation of overlapping peptides of human being’
SARS Virus M protein to diagonose SARS with linear B cell epitopes
of human being’ SARS Coronavirus M protein.
Methods: Analyze the hydrophilicity of Coronavirus M protein of
human being’ SARS using Genetyx-MAC9.0 soft. 164 overlapping
pepetides spanning of 6-mer were synthesized in the hydrophilic-
ity area with Auto-spot Robot. Taking a reaction of Dot-ElISA uses
the serum of 15 SARS patients and composing peptide chain.
Results: Several overlapping pepetides showed positve binding
with 15 patients with SARS, and ﬁve peptides seemed to be com-
mon epitope peptides. They are MKY1 (Gln-Len-Len-Gln-Gln-Trp-
Asn-Len-Val), MKY2 (Trp-Ph-Asn-Pro-Glu-Thr-Asn-Ile), MKY3 (Val-
Thr-Arg-Pro-Leu-Met-Glu-Ser), MKY4 (Ser-Tyr-Tyr-Lys-Leu-Gly-
Ala), MKY5 (Val-Gly-Thr-Asp-Ser-Gly-Phe-Ala-Ala-Tyr), sera did
not react with a control peptides, and normal sera also did not re-
act with pepetides of human being’ SARS Coronavirus M protein.
Conclusion: Taken together, these results point to linear B cell
epitopes of human being’ SARS Coronavirus M protein could
diagnose patients of SARS.
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Elaboration of mucosal vaccines involving biodegradable polymer
complexes is a topical problem. These polymers are capable of
protecting the virus from acid gastric medium and releasing the
virus in weakly alkaline intestinal medium. In addition, the ma-
jority of these polymers are capable of intensifying the immune
response to the antigen introduced.
The purpose of work was the choice of the polymer system for
effective viral vaccine development.
We used the following methods:
– microgranulation into a polymer matrix through atomization
of the viral material dissolved in polymeric solvent into a
liquid nitrogen,
– microencapsulation through forming the coating on a drop
containing the viral material, while contacting with solution
of the forming material,
– micro- and nanoencapsulation by cryocoacervation method.
– coacervation of viral suspensions in hydrophobic liquids into a
gelatin envelope.
The methods of transmission electron microscopy, atomic force
microscopy, freeze-fractography, determination of speciﬁc activ-
ity and immunogenicity were used to control of viral prepara-
tions.
According to our data, the most perspective method was the
cryocoacervation. The method proposed allows for production
of spherical or irregular-shaped particles with size of 0.1-10
μm. This method is universal and may be applied for micro-
and nanoencapsulation of different viruses and for design of
various viral vaccines. International PCT patent application was
submitted and registered as PCT/Ru/02/00465.
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Neeraj Gupta*, Jacob Puliyel, Ashutosh Shrivastava,
Samiksha Manchanda. St. Stephen’s Hospital
Background: Randomized control trials are difﬁcult to perform,
expensive and involve thorny ethical issues. CUSUM is a contin-
uous process of monitoring, used in industry that allows early
detection of deviations from the norm. We used CUSUM to study
3% saline nebulization (3%SN), a new treatment for bronchiolitis.
The response rate to standard therapy with nebulized adrenaline
(STNA) provided parameters within which 3% SN was evaluated.
Methods: Children 2 months to 2 years admitted with ﬁrst
episode acute bronchiolitis were recruited. In phase-one, STNA
was studied looking for improvement or deterioration on Downes
respiratory-distress-score. Downes score at admission could im-
prove or deteriorate during course of treatment. This provided
the stopping rule and also the thresholds beyond which 3% SN
can be considered as yielding more improvement than standard
therapy. A total of 35 children were enrolled in phase 1 and 28
received 3% SN in phase 2.
Results: The probability of deterioration with 3% SN was half
(1:14) compared to STNA (1:7) and 89.3% showed improve-
ment compared to 82.8%. Plotting these in sequence on the
CUSUM-chart allowed for continued use of the new therapy and
conﬁdence that it was not inferior to standard therapy.
Conclusion: Changes in score with treatment allowed the CUSUM-
graph to depict if the new intervention produced more adverse
events (crossing stopping threshold) or was signiﬁcantly better.
We found that 3% SN children had less deterioration than STNA
and there was a trend for more improvement. CUSUM, as we have
employed it, has potential in numerous medical evaluations.
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Background: EPI has obviously decreased the incidence of
measles, recently years locally outbreak still presence with
some new clinical features, all of these bring new challenges to
measles elimination.
Methods: We collected the clinical information detailed. 216
patients were divided into three groups: infants, children and
